Previous 10 | Next 10 |
FT MYERS, FL / ACCESSWIRE / December 13, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced the appointment of David Eberhard MD, PhD as Chief Medical Officer (CMO) of its liquid...
FT. MYERS, FL / ACCESSWIRE / December 10, 2021 / NeoGenomics, Inc. (NASDAQ:NEO) , a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced it will use Thermo Fisher Scientific's Ion Torrent Genexus System , the first turnkey next...
NeoGenomics (NASDAQ:NEO) is up 7.4% today after some insider buying. In SEC Filing, the company disclosed Chief Executive Officer Mark Mallon bought 17,000 shares on Monday. At price of $30.63, Mallon spent about $520,710 on shares. The move leaves him with direct beneficial ownersh...
FT. MYERS, FL / ACCESSWIRE / November 30, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that Mark Mallon, Chief Executive Officer, Bill Bonello, President - Informatics Divi...
BEIJING, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products ...
FT. MYERS, FL / ACCESSWIRE / November 10, 2021 / NeoGenomics, Inc. (NASDAQ:NEO) , a leading provider of cancer-focused genetic testing services and global oncology contract research services, has appointed Dave Daly to serve on its Board of Directors. Dave Daly joined our Board of Directors ...
China-based precision oncology platform Genetron Holdings (NASDAQ:GTH) has formed a strategic partnership with oncology laboratory solution provider NeoGenomics (NASDAQ:NEO) to drive global oncology drug research and development. The companies will partner globally to provide select harmonize...
BEIJING, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products ...
Image source: The Motley Fool. NeoGenomics, inc (NASDAQ: NEO) Q3 2021 Earnings Call Nov 5, 2021 , 2:00 p.m. ET Operator Continue reading For further details see: NeoGenomics, inc (NEO) Q3 2021 Earnings Call Transcript
The following slide deck was published by NeoGenomics, Inc. in conjunction with their 2021 Q3 earnings call. For further details see: NeoGenomics, Inc. 2021 Q3 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced that it will report its second quarter 2024 financial results after the close of the U.S. financial markets on Monday, July 29, 2024. Company management will host a webcast and conference call at 4:30 ...
2024-06-23 10:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced that Fort Myers’ Mayor, Kevin Anderson, will be dedicating June as NeoGenomics’ Commitment to Cancer Month to honor cancer survivors and those currently living with cancer. Headquartered in...